Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease

A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease

NCT06810960 ·Status: RECRUITING

Effect of LY2062430 on the Progression of Alzheimer's Disease

NCT00904683 ·Status: COMPLETED ·Phase: PHASE3

Effect of LY450139 on the Long Term Progression of Alzheimer's Disease

NCT00594568 ·Status: COMPLETED ·Phase: PHASE3

Effect of LY2062430 on the Progression of Alzheimer's Disease

NCT00905372 ·Status: COMPLETED ·Phase: PHASE3

Return of Amyloid Imaging Results (RAISR Study)

NCT03121118 ·Status: COMPLETED

An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease

NCT07153848 ·Status: RECRUITING

Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau

NCT05728736 ·Status: WITHDRAWN ·Phase: PHASE2

Network-Level Mechanisms for Preclinical Alzheimer's Disease Development

NCT03461861 ·Status: COMPLETED ·Phase: PHASE2

Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

NCT03703856 ·Status: COMPLETED ·Phase: PHASE4

Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

NCT02667496 ·Status: WITHDRAWN ·Phase: PHASE2

Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease

NCT03319810 ·Status: COMPLETED ·Phase: PHASE2

12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease

NCT07034222 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

NCT05063539 ·Status: COMPLETED ·Phase: PHASE2

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

NCT01044758 ·Status: COMPLETED ·Phase: PHASE2

Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients

NCT03514875 ·Status: WITHDRAWN ·Phase: NA

Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease

NCT02991235 ·Status: UNKNOWN ·Phase: NA

A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease

NCT01807026 ·Status: COMPLETED ·Phase: PHASE1

Cognitive Neurology Unit Clinical Registry

NCT05925621 ·Status: RECRUITING

A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities

NCT03639987 ·Status: TERMINATED ·Phase: PHASE2

The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy

NCT04309253 ·Status: RECRUITING ·Phase: PHASE2

Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease

NCT04576793 ·Status: RECRUITING ·Phase: PHASE2

Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab

NCT06741553 ·Status: RECRUITING

48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease

NCT04002583 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.

NCT00765115 ·Status: COMPLETED ·Phase: PHASE1

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

NCT02669225 ·Status: COMPLETED ·Phase: EARLY_PHASE1